Keywords: isis, begins, trials, anticancer, oligo, pharmaceuticals, started

Isis Begins Trials Of Anticancer Oligo

Article | 08 April 1996

Print This

Isis Pharmaceuticals has started Phase I clinical trials of a new antisense compound, ISIS 5132/CGP69846A, which acts as a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in